Literature DB >> 14759074

Determination of oxidative protein and lipid damage in adult hypopituitary patients with GH deficiency.

N Ozbey1, A Telci, U Cakatay, A Yurci, S Molvalilar.   

Abstract

The aim of this study is to determine oxidative protein and lipid damage in adult hypopituitary GH-deficient patients. Eighteen hypopituitary GH-deficient--otherwise healthy-adults on conventional replacement therapy other than GH (9 male, 9 female, age 41.8 +/- 16.4 yr) and 18 healthy subjects (6 male, 12 female, age 40.3 +/- 16.2 yr) participated in the study. Plasma products of oxidative protein damage [protein carbonyl (PCO) and nitrotyrozine (NT)], plasma oxidized LDL (oxLDL), plasma product of oxidative lipid damage [lipid hydroperoxide (LHP)] and antioxidant status of the plasma [total thiol (T-SH)] were measured. Body fat percentage, total and LDL-cholesterol concentrations were significantly higher in the hypopituitary group. Plasma PCO, NT, LHP and T-SH concentrations did not differ significantly between patients and controls. OxLDL concentration was significantly higher in the hypopituitary patients (62.4 +/- 17.8 vs 43.1 +/- 11.3 U/l, p = 0.001). In the patients, oxLDL correlated significantly with the duration of hypopituitarism (r = 0.6323, p = 0.01). In the controls, oxLDL correlated significantly with blood pressure, total and VLDL-cholesterol concentrations. Increased oxLDL concentration may indicate increased oxidative stress within the vascular compartment and may contribute to the proatherogenic state in GH-deficient hypopituitary patients independent from conventional risk factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14759074     DOI: 10.1007/BF03348199

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  42 in total

Review 1.  Cardiovascular disease and risk factors in adults with hypopituitarism.

Authors:  S A Beshyah; D G Johnston
Journal:  Clin Endocrinol (Oxf)       Date:  1999-01       Impact factor: 3.478

2.  Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma.

Authors:  J Nourooz-Zadeh
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

3.  Oxidative damage to proteins: spectrophotometric method for carbonyl assay.

Authors:  A Z Reznick; L Packer
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  Antibodies against oxidised low-density lipoprotein in hypopituitary patients with growth hormone deficiency.

Authors:  N Ozbey; A Aydin; A Telci; U Cakatay
Journal:  Endocr J       Date:  2001-10       Impact factor: 2.349

5.  Oxidative protein damage in plasma of type 2 diabetic patients.

Authors:  A Telci; U Cakatay; R Kayali; C Erdoğan; Y Orhan; A Sivas; T Akçay
Journal:  Horm Metab Res       Date:  2000-01       Impact factor: 2.936

6.  Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.

Authors:  M Pfeifer; R Verhovec; B Zizek; J Prezelj; P Poredos; R N Clayton
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

7.  Peroxynitrite-mediated oxidative protein modifications.

Authors:  H Ischiropoulos; A B al-Mehdi
Journal:  FEBS Lett       Date:  1995-05-15       Impact factor: 4.124

8.  Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults.

Authors:  V Markussis; S A Beshyah; C Fisher; P Sharp; A N Nicolaides; D G Johnston
Journal:  Lancet       Date:  1992-11-14       Impact factor: 79.321

9.  Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.

Authors:  P Holvoet; J Vanhaecke; S Janssens; F Van de Werf; D Collen
Journal:  Circulation       Date:  1998-10-13       Impact factor: 29.690

10.  Premature mortality due to cardiovascular disease in hypopituitarism.

Authors:  T Rosén; B A Bengtsson
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

View more
  3 in total

1.  Measurement of oxidative stress and endothelial dysfunction in patients with hypopituitarism and severe deficiency adult growth hormone deficiency.

Authors:  Daniel González-Duarte; Ainara Madrazo-Atutxa; Alfonso Soto-Moreno; Alfonso Leal-Cerro
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

2.  Paraoxonase is reduced in patients with growth hormone deficiency: A novel risk factor for atherosclerosis.

Authors:  Fahri Bayram; Gulden Baskol; Fatih Tanriverdi; Mevlut Baskol; Derya Kocer; Ayşen Caniklioğlu
Journal:  J Res Med Sci       Date:  2013-04       Impact factor: 1.852

3.  Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by growth hormone deficiency? A pilot study.

Authors:  Antonio Mancini; Francesco Guidi; Carmine Bruno; Flavia Angelini; Edoardo Vergani; Paola Lanza; Alvaro Mordente; Elisabetta Meucci; Andrea Silvestrini
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.